As the EU prepares to introduce regulatory sandboxes for medicines, attention turns to how the new tool can address regulatory hurdles for innovations that do not fit neatly within existing frameworks
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.